| Number of indicators with quantitative information a) | Number of studies | |
---|---|---|---|
n | % | ||
Early detection | 59 | 6% | Â |
Number of screening procedures | 33 | Â | 13 |
Early diagnosis and predisposition exams | 12 | Â | 7 |
Screening detection rates | 14 | Â | 5 |
Diagnosis and staging | 418 | 41% | Â |
Delay in access to diagnostic procedures | 9 | Â | 2 |
Clinical severity at diagnosis | 14 | Â | 7 |
Changes in cancer staging | 110 | Â | 21 |
Proportion of urgent/emergent referrals and procedures | 25 | Â | 5 |
Number of diagnostic, surveillance, and staging exams/procedures | 90 | Â | 17 |
Number of cancer diagnoses | 157 | Â | 40 |
Cancer detection rate | 13 | Â | 5 |
Treatment | 497 | 49% | Â |
Delay in treatment | 42 | Â | 18 |
Number of treatments | |||
 •Surgeries & loco-regional therapies | 104 |  | 30 |
 • Radiotherapy | 57 |  | 8 |
 • Systemic therapy | 71 |  | 12 |
 Number of referrals / first encounters | 41 |  | 9 |
 Outpatient volume | 47 |  | 14 |
 Changes in treatment | 119 |  | 21 |
 Number of visits and hospital admissions | 12 |  | 4 |
 Telemedicine utilization | 4 |  | 4 |
Outcomes | 39 | 4% | Â |
Surgical and procedures outcome measures | 15 | Â | 8 |
Mortality | 24 | Â | 4 |
 | 1013 | 100% |  |